Phosphatase-dependent regulation of desmosome intercellular junctions
Project Number1F32AR081677-01A1
Former Number1F32AR081677-01
Contact PI/Project LeaderPERL, ABBEY LEIGH
Awardee OrganizationNORTHWESTERN UNIVERSITY AT CHICAGO
Description
Abstract Text
Project Summary
Intercellular junctions and their cytoskeletal connections are essential for maintaining tissue stability and function.
This is particularly true of the multi-layered epidermis as it is exposed to high levels of mechanical stress while
maintaining an essential physical and immune barrier. Critical contributors to the epidermis' ability to maintain
the epidermal barrier while simultaneously adjusting to stress are attachments between keratin intermediate
filaments (IF) and intercellular junctions called desmosomes. Within desmosomes, a cytoskeletal linker protein
called desmoplakin (DP) is responsible for anchoring the IF to the junctions. DP is ubiquitously expressed in all
desmosome-forming cells and is regulated by post-translational modification (PTM) of its C-terminal tail domain
to control DP-IF affinity. Consistent with the importance of this phospho-regulatory region of DP for desmosome
function, genetic deletions of the C-terminal region cause multiple diseases associated with severe cardio-
cutaneous and lethal epidermal barrier defects. Functionally, when the C-terminal motif is in its hypo-
phosphorylated state, DP exhibits its highest affinity towards IF. In experimental models, the increased DP-IF
association had protective effects in mature cell sheets by generating stronger, more stable desmosomes.
Conversely, during desmosome assembly hypo-phosphorylated DP accumulates on the IF network, disrupting
it's trafficking to desmosome junctions, and interfering with the formation and maturation of new cell-cell
desmosome junctions. Given the strong molecular phenotypes associated with DP's hypo-phosphorylated form
in vitro, a coordinated process must exist to regulate DP phosphorylation for proper desmosome function. We
previously identified GSK3 as the kinase responsible for phosphorylating DP; however, the protein phosphatase
responsible for negatively regulating DP phosphorylation was previously unknown. My preliminary data identified
PP2A-B55 as capable of binding to and dephosphorylating DP's C-terminus. This proposal will test the
hypothesis that PP2A-B55 regulates DP phosphorylation during the dynamic process of desmosome
assembly and in response to mechanical stress to allow cells to respond to the changing properties and
specialized functions of the stratified epidermis. Aim 1 will employ cutting-edge microscopy and proteomics-
based approaches to identify the mechanism by which PP2A regulates DP during desmosome assembly. Aim 2
will establish how PP2A phospho-regulation of DP impacts 1) desmosome-dependent cell adhesion and 2) the
desmosomal response to mechanical stress using novel mechano-biology techniques. The proposed work will
provide important insight into how phosphatase signaling controls desmosome assembly and function to
maintain the human epidermal barrier and, therefore, how dysregulated phosphatase signaling could contribute
to barrier-related diseases. Together, the proposed research and career development plan will provide a
springboard for my development as an independent investigator and planned K99/R00 application.
Public Health Relevance Statement
Project Narrative
The machinery responsible for holding skin cells together is critical for the maintenance of tissue integrity and
barrier function of the stratified epidermis. This proposal will leverage cutting-edge microscopy and proximity-
labeling proteomics strategies to address how protein modifications of this critical machinery impacts the skin's
form and function. Together, the scientific insights into the mechanisms regulating this machinery, coupled with
the training opportunities proposed in this application will form the necessary foundation for my long-term
scientific and career goals.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
CFDA Code
846
DUNS Number
005436803
UEI
KG76WYENL5K1
Project Start Date
01-April-2023
Project End Date
31-March-2024
Budget Start Date
01-April-2023
Budget End Date
31-March-2024
Project Funding Information for 2023
Total Funding
$71,792
Direct Costs
$71,792
Indirect Costs
Year
Funding IC
FY Total Cost by IC
2023
National Institute of Arthritis and Musculoskeletal and Skin Diseases
$71,792
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1F32AR081677-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1F32AR081677-01A1
Patents
No Patents information available for 1F32AR081677-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1F32AR081677-01A1
Clinical Studies
No Clinical Studies information available for 1F32AR081677-01A1
News and More
Related News Releases
No news release information available for 1F32AR081677-01A1
History
No Historical information available for 1F32AR081677-01A1
Similar Projects
No Similar Projects information available for 1F32AR081677-01A1